Physicians with University of Minnesota Health Cancer Care make up an internationally recognized team known for its innovative and compassionate care for patients with blood cancers such as multiple myeloma. Many treatments that are now available to patients around the world were pioneered at our National Cancer Institute-designated research center: Masonic Cancer Center, University of Minnesota.
University of Minnesota Health Cancer Care has been a world leader in treating blood cancers like multiple myeloma with blood and marrow transplant (BMT) since 1968, when the world’s first successful BMT was completed here. Since then, our physicians have performed roughly 6,000 transplants for patients with leukemia, lymphoma, myeloma and other cancers of the blood.
We continue to perform leading-edge research in collaboration with scientists at the Masonic Cancer Center. This research often benefits patients who have failed standard therapies.